KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Change in Taxes (2016 - 2025)

Historic Change in Taxes for Cme (CME) over the last 17 years, with Q3 2025 value amounting to -$700000.0.

  • Cme's Change in Taxes rose 9678.9% to -$700000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $38.2 million, marking a year-over-year increase of 13220.91%. This contributed to the annual value of -$117.4 million for FY2024, which is 5226.98% down from last year.
  • Per Cme's latest filing, its Change in Taxes stood at -$700000.0 for Q3 2025, which was up 9678.9% from -$252.6 million recorded in Q2 2025.
  • In the past 5 years, Cme's Change in Taxes ranged from a high of $282.5 million in Q1 2023 and a low of -$332.5 million during Q2 2023
  • Over the past 5 years, Cme's median Change in Taxes value was -$4.6 million (recorded in 2021), while the average stood at -$22.9 million.
  • Examining YoY changes over the last 5 years, Cme's Change in Taxes showed a top increase of 16211.18% in 2022 and a maximum decrease of 241304.35% in 2022.
  • Quarter analysis of 5 years shows Cme's Change in Taxes stood at -$32.2 million in 2021, then skyrocketed by 162.11% to $20.0 million in 2022, then crashed by 53.0% to $9.4 million in 2023, then grew by 12.77% to $10.6 million in 2024, then tumbled by 106.6% to -$700000.0 in 2025.
  • Its Change in Taxes stands at -$700000.0 for Q3 2025, versus -$252.6 million for Q2 2025 and $280.9 million for Q1 2025.